41 studies found for:    Open Studies | "Hyperthyroidism"
Show Display Options
Rank Status Study
21 Unknown  Local Triamcinolone Injection in Active Thyroid Orbitopathy
Condition: Thyroid Disease
Intervention: Drug: Triamcinolone
22 Unknown  The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Interventions: Procedure: Total Thyroidectomy;   Drug: Propylthiouracil
23 Recruiting A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Intervention: Drug: methylprednisolone, prednisone
24 Recruiting Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function
Conditions: Thyroid Goiter;   Thyroid Carcinoma;   Multinodular Goiter;   Graves Diseases
Intervention: Procedure: Thyroidectomy and parathyroid reimplantation in forearm subcutaneous tissue
25 Recruiting Post-Radioiodine Graves' Management: The PRAGMA-Study
Condition: Graves' Disease
Intervention:
26 Unknown  Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
Condition: Eye Diseases
Intervention: Drug: Botulinum toxin A injection
27 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole
28 Recruiting Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Hyaluronic Acid Gel injection;   Drug: Saline injection
29 Not yet recruiting Selenium in Mild Thyroid Eye Disease in North America
Condition: Thyroid Associated Ophthalmopathies
Interventions: Dietary Supplement: Sodium selenite;   Dietary Supplement: Sugar pill
30 Recruiting Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Condition: Thyroid Associated Opthalmopathies
Interventions: Drug: Prednisone+placebo of Doxycycline;   Drug: Doxycycline+placebo of Prednisone
31 Not yet recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%
32 Not yet recruiting Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
Condition: Graves' Ophthalmopathy
Interventions: Drug: Bimatoprost;   Drug: Eye drop solution
33 Unknown  The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
Condition: Graves' Ophthalmopathy
Intervention:
34 Recruiting Early Levothyroxine Post Radioactive Iodine
Condition: Graves' Disease
Intervention: Drug: Levothyroxine
35 Unknown  A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery
Conditions: Multinodular Goitre;   Grave's Disease;   Thyroid Nodule
Intervention: Device: Ligasure Device
36 Unknown  Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
Condition: Thyroid-associated Ophthalmopathy
Intervention: Drug: subconjunctival triamcinolone injection
37 Unknown  Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Condition: Graves' Disease
Intervention:
38 Recruiting Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy
Condition: Graves Ophthalmopathy
Interventions: Procedure: blepharotomy;   Procedure: posterior approach
39 Recruiting Antithyroid Drug Treatment of Thyrotoxicosis in Young People
Condition: Paediatric Thyrotoxicosis
Interventions: Procedure: Block and Replace;   Procedure: Dose Titration;   Drug: carbimazole;   Drug: propylthiouracil;   Drug: thyroxine
40 Recruiting Teprotumumab Treatment in Patients With Active Thyroid Eye Disease
Conditions: Thyroid Associated Ophthalmopathies;   Thyroid-Associated Ophthalmopathy
Interventions: Drug: teprotumumab;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results
Indicates status has not been verified in more than two years